GLUCOMYRAL
LIVE

Serial Number

79420351

Owner

NUTRA FUTURA S.R.L.

Attorney

Theodore R. Remaklus

Filing Date

Feb 27, 2025

Add to watchlist:

No watchlists yet
View on USPTO

GLUCOMYRAL Trademark

Serial Number: 79420351 • Registration: 8112917

GLUCOMYRAL is a trademark filed by NUTRA FUTURA S.R.L. on February 27, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NUTRA FUTURA S.R.L.

Via Monte Generoso 6A

Entity Type: 16

Trademark Details

Filing Date

February 27, 2025

Registration Date

January 27, 2026

Published for Opposition

December 9, 2025

Goods & Services

Pharmaceuticals, medical and veterinary preparations, namely, pharmaceutical preparations for wounds, for treating allergies, treating hypertension, and for skin care, medical preparations, namely, bath preparations for medical purposes, mineral preparations for medical purposes, and glucose preparations for medical purposes, and veterinary preparations, namely, enzyme preparations for veterinary purposes, bacteriological preparations for veterinary purposes, and diagnostic preparations for veterinary purposes; dietetic food and substances adapted for medical or veterinary use, and food for babies; food supplements for humans and animals; food supplements and dietetic preparations adapted for medical purposes; nutritional supplements for medical use; dietary foods for medical use, namely, dietetic foods adapted for medical use; dietetic beverages for medical use; food supplements for humans, not for medical use; vitamin supplements; nutritional supplements; protein food supplements; vitamin and mineral supplements; probiotic supplements; food supplements, namely, antioxidant supplements; anti-inflammatory preparations; mineral food supplements; nutraceutical preparations for therapeutic or medical use, namely, nutraceuticals for the treatment of high cholesterol and nutraceuticals for use as a dietary supplement for promoting digestion; nutraceuticals for use as dietary supplements; phytotherapy preparations for medical use; herbal extracts, other than essential oils, for medical use; extracts, other than essential oils, of medicinal plants and herbs; plant extracts, other than essential oils, for pharmaceutical use; dietary fibre, namely, dietary fibre for treating constipation, dietary fibre to aid digestion, and dietary fiber for use as an ingredient in the manufacture of dietary supplements; vitamins; nutritional supplements not for therapeutic use; milk ferments for pharmaceutical use; cultures of microorganisms for dietary supplements; cultures of microorganisms for medical and veterinary use; anti-microbial preparations, namely, anti-microbial hand-sanitizing preparations, anti-microbial preparations for preventing mold, mildew, and bacteria, and antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed, and pharmaceuticals; bacterial preparations for medical or veterinary use; biological preparations for medical and veterinary use, namely, biological preparations for the treatment of cancer, biological preparations for the prevention and treatment of cancer, infectious diseases and viral infections, and biologics in the nature of pharmaceutical preparations for the treatment of cancer; preparations of microorganisms for medical or veterinary use; medical preparations for personal hygiene or for sanitary use, namely, disinfectants for hygiene purposes, sterilizing preparations, chemical preparations for sanitary purposes, and sanitary preparations for medical use

Chemicals for use in the pharmaceutical industry; chemical preparations for use in the food industry; chemicals for use as ingredients during production in the pharmaceutical, food, and supplement industries; active chemical ingredients for use in the manufacture in the pharmaceutical, food, and supplement industries; chemicals for industrial use in the production of dietary supplements, nutritional supplements, nutraceutical supplements, food supplements, vitamin supplements, and supplements containing microorganisms; chemicals for industrial use in the production of pharmaceuticals, medical and veterinary preparations, food and dietary substances for medical or veterinary use, and food supplements for humans and animals; plant extracts, other than essential oils, for industrial use in the production of pharmaceuticals and food supplements; plant extracts, other than essential oils, for industrial purposes; botanical extracts, other than essential oils, for industrial use used in the manufacture of pharmaceuticals, medical and veterinary preparations, foods and dietary substances for medical or veterinary use, and food supplements for humans and animals; plant extracts, other than essential oils, for the food industry; herbal extracts, other than for essential oils, for the production of pharmaceuticals; preparations of microorganisms not for medical or veterinary use; bacteriological preparations not for medical or veterinary use; cultures of microorganisms for industrial purposes; cultures of microorganisms for the food and supplement industry; bacteriological preparations for the food and supplement industry; milk ferments for the food and supplement industry

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 27, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 27, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 27, 2026 R.PR
NOTIFICATION PROCESSED BY IB
Dec 11, 2025 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2025 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2025 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 25, 2025 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 12, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 12, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 12, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 12, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 12, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 11, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 11, 2025 TROA
REFUSAL PROCESSED BY IB
Oct 3, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 13, 2025 RFCS
REFUSAL PROCESSED BY MPU
Sep 13, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 5, 2025 RFCR
NON-FINAL ACTION WRITTEN
Aug 4, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 31, 2025 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Jul 18, 2025 NREP
APPLICATION FILING RECEIPT MAILED
Mar 31, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 31, 2025 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Mar 27, 2025 SDRC